SCLX
Scilex Holding Company
NASDAQ · USHealthcareDrug Manufacturers - General
$7.64-9.48%
Price as of Jul 20, 2026
SCLX capital
Scilex Holding Company capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -0.43x
- Net debt / equity
- -0.41x
- Debt / assets
- 0.36x
- Debt / EBITDA
- -0.28x
- Net debt / EBITDA
- -0.28x
Liquidity & coverage
- Current ratio
- 0.08x
- Quick ratio
- 0.07x
- Cash ratio
- 0.01x
- Interest coverage
- -21.69x
- EBITDA / interest
- -29.34x
- Working capital
- -$459.8M
Cash & dividend
- FCF / debt
- -0.06x
- Cash flow / debt
- -0.03x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.